Skip to main content
The Journal of Clinical Hypertension logoLink to The Journal of Clinical Hypertension
. 2026 Apr 1;28(4):e70246. doi: 10.1111/jch.70246

The Optimal Dosage of Isometric Handgrip Exercise for Blood Pressure Reduction: Systematic Review and Meta‐Analysis

Chia‐Wei Lin 1,2, Ian B Jun 2, Vincent Igbo 2, Amir Babaniamansour 2, Lingyue Meng 2, Cheng‐Feng Lin 1,3, Yih‐Kuen Jan 2,✉
PMCID: PMC13045435  PMID: 41922197

ABSTRACT

The systematic review and meta‐analysis aimed to examine the dose‐response relationship between isometric handgrip (IHG) training and blood pressure outcomes in normotensive and hypertensive populations. Three databases (EMBASE, MEDLINE/PubMed, and Cochrane CENTRAL) were searched from inception to June 2025. Thirty‐one studies with 905 participants (51% male) met the criteria. Primary outcomes were resting systolic (SBP) and diastolic blood pressure (DBP). Study quality was assessed using the PEDro scale and RoB‐2. Meta‐regression was used to evaluate dose‐response effects on SBP and DBP. The included studies demonstrated fair to good methodological quality (5.9 ± 1.0). Moderate evidence indicated that IHG reduced SBP (–5.38 mmHg, 95% CI –6.91 to –3.85; p < 0.001; I 2 = 86% and DBP (–2.71 mmHg, 95% CI –3.75 to –1.66; p < 0.001; I 2 = 90%), with greater effects observed in hypertensive compared to normotensive groups. For meta‐regression, lower training intensity protocols (<30% of maximal voluntary isometric contraction [MVIC]) yield smaller blood pressure‐lowering effects in both SBP (p = 0.043) and DBP (p = 0.032). Higher weekly frequency (e.g., >3 to 7 days/week) was associated with a diminished effect in SBP (p = 0.032). In conclusion, the IHG training significantly lowers SBP and DBP in both normotensive and hypertensive individuals, offering preventive benefits for normotensive individuals at risk for hypertension and therapeutic potential for hypertensive patients. The evidence‐informed protocol might appear to be four sets of 2‐min unilateral contractions at ≥30 MVIC, performed ≤3 times per week for a minimum of 8 weeks. These findings support IHG as a practical non‐pharmacological strategy for blood pressure management.

Registration: PROSPERO number: CRD420251154235

Keywords: duration, high blood pressure, intensity, isometric exercise

1. Introduction

Hypertension is the most common cardiovascular risk factor and is strongly associated with adverse outcomes, such as stroke [1] and heart disease [2]. It is estimated that approximately 7.5 million deaths each year, accounting for about 12.8% of all global deaths [3], are attributable to elevated blood pressure (BP). Therefore, effective control of hypertension is essential for managing risk for cardiovascular diseases. Emerging evidence also supports the efficacy of isometric handgrip (IHG) in lowering BP [4, 5, 6, 7, 8], which has led to its inclusion in recent clinical guidelines [9, 10].

Despite a consensus on the benefits of IHG for BP management, variations in IHG protocols exist between clinical guidelines. European Society of Cardiology (ESC) [9] recommends low‐to‐moderate‐intensity with three sets of 1–2 min isometric contractions, whereas the American Heart Association (AHA) [10] specifies a protocol of four 2‐min isometric contractions at 30%–40% of maximal voluntary isometric contraction (MVIC) with a 1‐min rest interval between sets, performed three times per week for 8–10 weeks. Furthermore, although a recent systematic review [11] supports the efficacy of low‐intensity IHG training in reducing BP among adults with prehypertension and hypertension, the definition of “low intensity” remains largely unclear. Specifically, among the studies included in the review [11], 10 studies employed a training intensity of 30% MVIC and only one utilized 20% MVIC. In addition to differences in training intensity, there was considerable variability in other key parameters of isometric exercise protocols, including the number of weeks of intervention (ranging from 6 to 12 weeks), weekly training frequency (ranging from 3 to 7 days), and the duration of each contraction (ranging from 10 to 120 s). Such inconsistencies in existing IHG protocols present a challenge for establishing standardized exercise prescriptions and hinder the formulation of clear clinical guidelines [12].

Previous studies [13, 14, 15, 16, 17] have investigated the effects of varying IHG training intensities and durations on BP changes, but their findings remain inconclusive due to differences in training intensity and participant populations. A randomized controlled trial (RCT) [14] in hypertensive men found that both 30% MVIC (four 2‐min contractions) and high‐intensity training at 60% MVIC (eight 30‐s contractions), performed three times per week for 8 weeks, significantly improved resting BP, with statistically similar reduction of SBP but greater reductions observed in the high‐intensity group of DBP. Another RCT study [15] demonstrated that a 12‐week IHG training protocol at 15% of MVIC, performed three times per week, significantly reduced SBP by approximately 4.0 mmHg in hypertensive adults. However, another RCT [16] found that performing 2‐min IHG contractions at 5% of MVIC, three times per week for 8 weeks, did not significantly reduce SBP in hypertensive individuals, in contrast to a greater reduction observed with 30% MVIC. On the other hand, one study [13] involving normotensive adults investigated low‐intensity IHG training at 5% or 10% MVIC (four 2‐min contractions, three times per week for 6 weeks) and observed a modest reduction in SBP. Although these changes did not reach a statistical significance, they were considered clinically meaningful. However, variations in training dosage, including the intensity, intervention length, frequency, and contraction duration, limit the comparability and generalizability of the findings, given that these parameters differed between studies.

Most previous studies [15, 18] have employed IHG interventions lasting between 4 and 8 weeks, with a frequency of 2–4 times per week in hypertensive individuals. However, this wide range makes it difficult to establish clear guidelines for clinical application. A study [19] reported a significant decrease in SBP as early as the fourth week of IHG training (four 2‐min contractions at 30% MVIC, performed three times per week), with a reduction of 11.2 mmHg observed in hypertensive patients. Regarding the training frequency, no studies to date have directly compared different session frequencies of IHG training in hypertensive patients. However, one RCT study  [20] conducted in normotensive adults compared four 2‐min IHG contraction at 30% of MVIC, performed either two or four times per week over a 4‐week period. The results demonstrated significant reductions in SBP in both groups for two times per week and four times per week, with no significant difference between the two intervention frequencies. However, discrepancies in participant characteristics, namely normotensive versus hypertensive populations, limit the generalizability of the finding, as the underlying physiological mechanisms of BP regulation may differ. Therefore, a more systematic investigation is needed to clarify the dose‐responses relationship between IHG training intensity and BP outcomes across normotensive and hypertensive populations.

Currently, there is no standardized clinical guideline regarding the dosage of IHG exercise for lowering BP, including key parameters such as the percentage of MVIC, duration, frequency, and intervention length. Therefore, establishing a clear and evidence‐based guideline is essential for clinical practice. The purpose of current systematic review and meta‐analysis was to investigate the evidence‐informed dosage of IHG for BP reduction, including determining appropriate IHG exercise dosage for hypertensive and normotensive populations, respectively.

2. Methods

2.1. Literature Search

The systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines [21] by two of the authors and was prospectively registered in the International Prospective Register of Systematic Reviews. A comprehensive search of EMBASE, MEDLINE/PubMed, and Cochrane CENTRAL was conducted from database inception through June 2025, using a combination of relevant Medical Subject Headings (MeSH) and free‐text keywords to identify studies addressing the participants, interventions, and outcomes described in Table S1.

2.2. Inclusion and Exclusion Criteria

Study selection followed the PICOS framework (Population, Intervention, Comparison, Outcome, and Study design. (1) Population: adults aged ≥18 years, including healthy control, prehypertension, and hypertension. Studies involving pregnant women or individuals with stroke, heart failure, or chronic kidney disease were excluded. (2) Intervention: exclusively used the IHG exercise, excluding those that combined it with any other type of exercise or any other therapy. The duration was restricted ≥2 weeks. (3) Comparison: baseline (pre‐intervention) values served as comparators for evaluating the effects of the intervention. (4) Outcomes: studies were required to report both baseline and post‐intervention BP measurements for SBP and DBP. (5) Study design: encompassed all human studies, including RCTs. Systematic reviews, meta‐analyses, conference abstracts, case reports, dissertations, observational studies, quasi‐experimental designs and studies not published in English were excluded.

2.3. Study Selection and Data Extraction

Two reviewers (C.W.L. and L.M.) independently screened the titles and abstracts of all retrieved records to identify studies that met the inclusion criteria. Full‐text articles were retrieved for potentially eligible studies. All references were managed in EndNote 21 (Clarivate, Philadelphia, PA, USA), where duplicate entries were removed. Any discrepancies were resolved by consensus, with a third reviewer (Y.K.J.) consulted when necessary. Data extraction was performed by one reviewer (C.W.L.) using a standardized form, which included study identifiers (authors and year), allocation methods, inclusion criteria, participant characteristics, intervention characteristics, and training content.

2.4. Data Extraction

Data were extracted using a standardized form to systematically collect relevant information from each study. Extracted variables included the first author, year of publication, sample size, and baseline and post‐intervention means and standard deviations (SDs) for each outcome. To determine the specific IHG dose per session, only the minutes of the training phase were considered, excluding warm‐up and cool‐down periods. When session duration was reported as a range (e.g., 1–3 min), the midpoint value (e.g., 2 min) was used as the estimated session length.

2.5. Risk of Bias Assessment and PEDro Assessment

Risk of bias was assessed using the Cochrane Risk of Bias Tool for Randomized Controlled Trials (ROB‐2) [22]. It evaluates five domains: the randomization process, deviations from intended interventions, missing outcome data, measurement of outcomes, and selection of the reported results. Each domain was rated as “low risk of bias,” “some concerns,” or “high risk of bias.” The overall risk of bias judgment for each study was determined by the highest risk rating across the five domains. Two researchers (A.B. and I.J.) independently reviewed the trials, and any discrepancies were resolved by a third researcher (C.W.L.).

The methodological quality of the included studies was evaluated using the Physiotherapy Evidence Database (PEDro) scale [23]. This 11‐item tool assesses aspects such as eligibility criteria, random allocation, concealed allocation, baseline comparability, blinding of participants, therapists, and assessors, adequacy of follow‐up, intention‐to‐treat analysis, between‐group comparisons, and reporting of point estimates with variability measures. The total PEDro score is derived from the final 10 items. Studies were categorized by quality as excellent (9–10), good (6–8), fair (4–5), or poor (≤3). When available, PEDro scores were extracted directly from the PEDro database, which contained committee‐assigned ratings for three of the included studies. For studies not listed in the database, two reviewers (I.B. and V.L.) independently conducted assessments according to PEDro guidelines [23]. Any disagreements were resolved through by third reviewer (C.W.L.).

2.6. Certainty of Evidence

Based on the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach, two researchers (C.W.L. and A.B.) independently evaluated the certainty of the evidence and any discrepancies were resolved by a third researcher (Y.K.J.). The certainty of evidence was categorized into four levels: very low, low, moderate, and high. The criteria for downgrading the certainty of evidence were as follows. (1) Risk of bias: downgraded by one level if ≥25% of the included studies for an outcome were rated as high risk of bias according to ROB‐2. (2) Inconsistency: downgraded by one level if substantial heterogeneity was present (I2 ≥ 75%). (3) Indirectness: downgraded by one level if important differences existed in participants, interventions, outcome measures, or indirect comparisons. (4) Imprecision: downgraded if the 95% confidence interval included the null effect and/or if the sample size was small (n < 300). (5) Publication bias: downgraded if evidence of asymmetry was detected through visual inspection of funnel plots.

2.7. Data Synthesis and Analysis

Data synthesis and analysis were conducted using Review Manager (RevMan, version 5.4; Nordic Cochrane Centre, Cochrane Collaboration, Copenhagen, Denmark). All analyses were performed using a random‐effects model. Standardized mean differences (SMDs), mean difference (MDs) of SBP and DBP and their 95% confidence intervals (CIs) were obtained. The SMDs interpreted according to the following thresholds: trivial (<0.2), small (0.2–0.6), moderate (0.6–1.2), large (1.2–2.0), very large (2.0–4.0), and extremely large (>4.0). Statistical heterogeneity was assessed using the I2 statistic, categorized as unimportant (0%–40%), moderate (30%–60%), substantial (50%–90%), or considerable (75%–100%). The calculation of the risk of publication bias across all the studies was indicated by using funnel plots/graphs. The sensitivity analyses were conducted by restricting the meta‐analysis to studies with low risk of bias.

Exercise intervention parameters were classified according to recent literature [24]. These classifications were based on their influence on the dosage design of IHG exercise and are commonly used to guide training protocols. The parameters included sets, minutes per contraction, laterality, %MVIC, rest interval, days per week, and total intervention weeks. The SMDs values with 95% CIs that did not cross zero were defined as significant, whereas those with 95% CIs crossing zero were defined as non‐significant, and the frequencies were tabulated accordingly.

To evaluate the relationship between exercise dose (set, minutes per contraction, laterality, %MVIC, rest interval, days per week, and total intervention weeks) and SMD of SBP and DBP, the meta‐regression was conducted. Scatterplot diagrams were used to plot data and visually determined the types of association between independent and dependent variables. For linear associations, data were analyzed using their raw values. In cases where curvilinear associations were identified, data were recalculated using logarithmic transformations (for log‐shaped associations) or Taylor series approximations (for U‐shaped associations) to achieve linearity for the regression analysis. Random‐effects meta‐regression models with random study intercepts and fixed moderator slopes, estimating the between‐study variance (τ2) via restricted maximum likelihood (REML). The dependent variables were SMD of SBP and DBP, respectively, while the independent variables were: set [minutes, log‐transformed], minutes/set [minutes], MVIC [%], rest interval [minutes, U‐shaped], laterality [factor], days/week [days, log‐transformed], and duration [weeks]. The partial meta‐regression coefficients (B) with 95% CIs and p values were estimated. The statistical analyses were performed in R software (version 4.2.1), with the level of significance set at p < 0.05.

3. Results

3.1. Literature Search

A total of 2766 were retrieved from the three databases. After removing 912 duplicates, 1854 articles remained for screening. Two reviewers (C.W.L. and L.M.) independently screened the titles and abstracts, of which 118 articles met the inclusion criteria for full‐text review. Two full texts could not be retrieved. Among the 116 full‐text articles assessed, 84 studies were excluded due to reasons such as the absence of post‐intervention BP measurement, lack of BP data, publication in a non‐English language, inappropriate study design, wrong population, or being only a study protocol. In addition, five records were identified from citation searching. Ultimately, 38 records and identified 34 studies were included in the final systematic review (Figure 1). Three studies did not present the values of the outcome measures and were therefore excluded from the following analysis, leaving 31 studies in the current study.

FIGURE 1.

FIGURE 1

PRISMA flow diagram of study selection.

3.2. Study Quality and Risk of Bias

Both the study quality and risk of bias ratings are summarized in Table 1. The overall study quality ranged from 3 to 8 points, with a mean score of 5.9 ± 1.0 points on the PEDro scale, indicating that the methodological quality of the included studies ranged from fair to good. The heat map of risk of bias is presented in Figure 2.

TABLE 1.

Methodological quality of included studies assessed using the PEDro scale.

Eligibility criteria Random allocation Conceal allocation Baseline comparability Blind subjects Blind therapists Blind assessors Adequate follow‐up Intention‐to‐treat analysis Between‐group comparisons Point estimates and variability Total score Level of quality
Badrov et al. (2013) [32] 1 1 0 1 0 0 0 0 0 1 1 4 Fair
Badrov et al. (2013) [33] 1 1 0 1 0 0 0 1 1 1 1 6 Good
Baross et al. (2017) [26] 1 1 0 1 0 0 0 1 1 1 1 6 Good
Cahu Rodrigues et al. (2019) [34] 1 1 1 1 0 0 1 1 0 1 1 7 Good
Carlson et al. (2016) [16] 1 1 0 1 0 0 0 1 1 1 1 6 Good
Chen et al. (2025) [20] 1 1 1 1 0 0 0 1 1 1 1 7 Good
Cohen et al. (2023) [19] 1 1 0 1 0 0 0 1 1 1 1 6 Good
Danielsen et al. (2023) [35] 1 1 1 1 0 0 1 1 1 1 1 8 Good
Farah et al. (2018) [36] 1 1 1 1 0 0 1 0 0 1 1 6 Good
Fecchio et al. (2023) [37] 1 1 1 1 0 0 0 1 0 1 1 6 Good
Goessler et al. (2018) [27] 1 1 0 1 0 0 0 1 0 1 1 5 Fair
Herrod et al. (2021) [38] 0 1 1 0 0 0 0 1 0 1 1 5 Fair
Hess et al. (2016) [13] 1 1 0 1 0 0 0 1 0 1 1 5 Fair
Jae et al. (2024) [39] 1 1 0 1 0 0 0 1 0 1 1 5 Fair
Millar et al. (2008) [28] 1 1 0 1 0 0 0 1 1 1 1 6 Good
Nemoto et al. (2021) [40] 1 1 0 1 0 0 0 1 1 1 1 6 Good
Nemoto et al. (2025) [15] 1 1 0 1 0 0 0 1 0 1 1 5 Fair
Ogbutor et al. (2019) [41] 1 1 1 1 0 0 0 1 1 1 1 7 Good
Okamoto et al. (2020) [42] 0 1 0 1 0 0 1 0 0 1 1 5 Fair
Pagonas et al. (2017) [43] 1 1 0 1 0 0 0 1 1 1 1 6 Good
Palmeira et al. (2021) [44] 1 1 1 1 0 0 1 0 1 1 1 7 Good
Pinto et al. (2025) [45] 1 1 1 1 0 0 1 1 0 1 1 7 Good
Punia & Kulandaivelan (2020) [46] 1 1 1 1 0 0 1 1 1 1 1 8 Good
Ray & Carrasco (2000) [25] 1 1 0 1 0 0 0 1 1 1 1 6 Good
Silva de Sousa et al. (2024) [47] 1 1 0 1 0 0 0 0 1 1 1 5 Fair
Stiller‐Moldovan et al. (2012) [48] 0 1 0 1 0 0 0 0 0 1 1 4 Fair
Sultana et al. (2024) [49] 1 1 0 1 0 0 0 1 1 1 1 6 Good
Taylor et al. (2003) [50] 1 1 0 1 0 0 0 1 0 1 1 5 Fair
Verma et al. (2024) [29] 1 1 0 1 0 0 0 1 1 1 1 6 Good
Yamagata & Sako (2020) [30] 0 1 0 1 0 0 0 1 0 1 1 5 Fair
Zhang et al. (2024) [55] 1 1 0 1 0 0 0 1 1 1 1 6 Good

Note: 0, no; 1, yes.

FIGURE 2.

FIGURE 2

Risk of bias (ROB‐2) heat map for included studies.

3.3. Study and Participants Characteristics

For 31 RCT studies, 30 RCTs and one randomized crossover study were included in the analysis (Table 2).

TABLE 2.

Study characteristics.

Author (year) Study design Participant characteristics Subgroups Pharmacological treatment Intervention characteristics
Badrov et al. (2013a) [32] RCT Hypertension, 6 M/6F, 65 ± 7 years, 169 ± 9 cm, 77 ± 13 kg, 27 ± 4 kg/m2 Hypertension Overall medication use: 83% 4 × 2‐min with 30% MVIC, 3 times/week for 10 weeks, 1‐min rest interval, bilateral hands
Badrov et al. (2013b) [33] RCT

Low frequency group

Normotensive women, 0M12F, 23 ± 4 years, 165 ± 5 cm, 58 ± 6 kg, 21 ± 2 kg/m2

Normotension None 4 × 2‐min with 30% MVIC, 3 days/week for 8 weeks, 4‐min rest interval, non‐dominant hand

High frequency group

Normotensive women, 0M11F, 27 ± 6 years, 162 ± 8 cm, 59 ± 12 kg, 23 ± 4 kg/m2

Normotension None 4 × 2‐min with 30% MVIC, 5 days/week for 8 weeks, 4‐min rest interval, non‐dominant hand
Baross et al. (2017) [26] RCT Normotensive sedentary participants, 6M6F, 20.7 ± 1.6 years; 66.9 ± 8.8 kg; 176.6 ± 6.7 cm; 21.6 ± 0.6 kg/m2 Normotension None 3 × 10‐s with 20% MVIC, 4 days/week for 6 weeks, alternative hand at 5, 15, 25 min
Cahu Rodrigues et al. (2019) [34] RCT Hypertensive patients, 6M11F (converted by percentage), 61 ± 2 years, 84.2 ± 3.1 kg, height: 162 ± 2 cm, 32.0 ± 1.0 kg/m2 Hypertension 12% CCB, 59% DIU, 23% β‐blocker, 23% ACE inhibitor, 71% ARB 4 × 2‐min with 30% MVIC, 3 days/week for 12 weeks, 1‐min rest interval, alternating hands
Carlson et al. (2016) [16] RCT

30% MVIC group

Hypertensive adults,

7M13F, 52 ± 8 years, 170 ± 9 cm, 88 ± 16 kg, 30 ± 6 kg/m2

Hypertension 15% ACEi, 15% ARB, 5% CCB, 5% ACEi+CCB, 5% ARB+CCB, 5% ACEi+ DIU, 10% ARB+DIU, 5% ACEi+CCB+DIU, 35% Unmedicated (percentages were calculated by authors) 4 × 2‐min with 30% MVIC, 3 days/week for 8 weeks, 3‐min rest interval, nondominant hand

5% MVIC group

Hypertensive adults,

8M12F, 54 ± 8 years, 171 ± 8 cm, 87 ± 19 kg, 30 ± 6 kg/m2

Hypertension 15% ACEi, 25% ARB, 5% ARB+CCB, 10% ACEi+CCB+DIU, 5% ARB +CCB+DIU, 5% α‐blocker+ CCB+DIU, 35% Unmedicated (percentages were calculated by authors) 4 × 2‐min with 5% MVIC, 3 days/week for 8 weeks, 3‐min rest interval, nondominant hand
Chen et al. (2025) [20] RCT

Low frequency group

Young normotensive, 2M18F, 23 ± 4 years,.163 ± 7 cm, 62.8 ± 14.4 kg, 23.6 ± 4.2 kg/m2

Normotension None 4 × 2‐min with 30% MVIC, 2 days/week for 4 weeks, 2‐min rest interval, dominant hand

High frequency group

Young normotensive, 7M13F, 23 ± 5 years, 169 ± 9 cm, 67.9 ± 17.7 kg, 23.6 ± 4.0 kg/m2

Normotension None 4 × 2‐min with 30% MVIC, 4 days/week for 4 weeks, 2‐min rest interval, dominant hand
Cohen et al. (2023) [19] RCT Non‐medicated people with hypertension, 52M25F, 44.9 ± 9.6 years, 81.4 ± 10.5 kg, 28.3 ± 2.9 kg/m2, no report of height Hypertension Unmedicated 4 × 2‐min with 30% MVIC, 3 times/week for 12 weeks, 2‐min rest interval, unilateral hand
Danielsen et al. (2023) [35] RCT Hypertensive patients, 15M9F, 65.2 ± 7.2 years, 172.9 ± 9.4 cm, 76.4 ± 13.2 kg, 25.5 ± 3.3 kg/m2 Hypertension Overall medication use: 75% 4 × 2‐min with 30% MVIC, 3 days/week for 20 weeks, 1‐min rest interval, alternating hands
Farah et al. (2018) [36] RCT

Home‐based group

Stage 1hypertensive adults, 6M4F, 52.0 ± 2.4years, 168.6 ± 2.9 cm, 89.1 ± 5.9 kg, 30.7 ± 1.6 kg/m2

Hypertension 33% ACEi, 77% ARB, 17% CCB, 44% DIU, 22% β‐blocker 4 × 2‐min with 30% MVIC, 3 days/week for 12 weeks, 1‐min rest interval, alternating hands

Supervised group

Stage 1hypertensive adults, 6M4F, 50.6 ± 2.3 years, 169.6 ± 2.7 cm, 85.1 ± 6.0 kg, 29.3 ± 1.6 kg/m2

Hypertension 6% ACEi, 81% ARB, 19% CCB, 38% DIU, 20% β‐blocker 4 × 2‐min with 30% MVIC, 3 days/week for 12 weeks, 1‐min rest interval, alternating hands
Fecchio et al. (2023) [37] RCT Middle‐age hypertensive men with treated, 15M0F, 55 ± 7 years, 174 ± 8 cm, 86 ± 15 kg, 28.1 ± 3.5 kg/m2 Hypertension Overall medication use: 100%; 73% ARB, 7% ACEi, 33%CCB, 40% DIU, 20% Statins 4 × 2 min with 30%MVIC, 3 days/week for 10 weeks, 1‐min rest interval, alternating hands
Goessler et al. (2018) [27] RCT

Normal healthy, 10M12F

33.1 ± 2.1 years, 171.4 ± 7.5 cm, 78.6 ± 3.2 kg, 26.8 ± 1.0 kg/m2

Normotension None 4 × 2 min with 30% MVIC, 7 days/week for 8 weeks, 1‐min rest interval, bilateral hands
Herrod et al. (2021) [38] RCT Healthy older adults, 71 ± 4 years (overall for four groups), 4M7F, no report of height, weight, and BMI Hypertension Medication status unclear (not reported) 4 × 2‐min with 30% MVIC, 3 days/week for 6 weeks, 2‐min rest interval, dominant hand
Hess et al. (2016) [13] RCT

5% MVIC group

Normotensive participants, 6M4F, 38.8 ± 10.5 years, 172 ± 10 cm, 83.3 ± 21.4 kg, 28.4 ± 7.7 kg/m2

Normotension None 4 × 2‐min with 5% MVIC, 3 days/week for 6 weeks, 1‐min rest interval, nondominant hand

10% MVIC group

Normotensive participants,

6M4F, 38.7 ± 12.6 years, 175 ± 10 cm, 85.3 ± 26.9 kg, 27.7 ± 7.4 kg/m2

Normotension None 4 × 2‐min with 10% MVIC, 3 days/week for 6 weeks, 1‐min rest interval, nondominant hand
Jae et al. (2024) [39] RCT Old hypertensive participants, 5M12F, 67 ± 6 years, 67.3 ± 9.1 kg, 26.5 ± 3.0 kg/m2, no report of height Hypertension 29.4% ARB, 11.8% CCB, 29.4% ARB+CCB, 11.8% β‐blocker+CCB, 5.9% ARB+DIU, 11.8% unmedicated (numbers given, percentages derived by authors) 4 × 2‐min with 30% MVIC, 3 days/week for 12 weeks, 1 min rest interval, bilateral hands
Millar et al. (2008) [28] RCT Normotensive regular exercise adults, 14M11F, 66 ± 1 years, no report of height, weight, and BMI Normotension None 4 × 2‐min with 30%–40% MVIC, 2 times/week for 8 weeks, 1‐min rest interval, alternating
Nemoto et al. (2021) [40] Randomized crossover trial

8 weeks of IHG then 8 weeks of usual activity

Hypertensive patients, 14 M, 13F, 62.3 ± 11.7 years, 163.5 ± 10.2 cm, 25.2 ± 3.1 kg/m2, no report of weight

Hypertension Overall medication use: 74.1%; 51.9% CCB, 48.2% ANG II B, 25.9% DIU, 0.0% β blocker, 14.8% Others 4 × 2‐min with 30% MVIC, ≥3 days/week for 8 weeks, 1‐min rest interval, alternating hands

8 weeks of usual activity then 8 weeks IHG

Hypertensive patients, 16M10F, 61.2 ± 13.3 years, 163.2 ± 10.9 cm, 25.5 ± 3.9 kg/m2, no report of weight

Hypertension Overall medication use: 61.5%; CCB, 65.4% ANG II B, 23.1% DIU, 7.7% β‐blocker, 15.4% Others 4 × 2‐min with 30% MVIC, ≥3 days/week for 8 weeks, 1‐min rest interval, alternating hands
Nemoto et al. (2025) [15] RCT Hypertensive patients, 12M17F, 68.1 ± 10.9 years, 159.5 ± 7.8 cm, 24.4 ± 3.6 kg/m2, no report of weight Hypertension Overall medication use: 86.2%; 86.2% CCB, 69.0% ANG II B, 20.7% DIU, 6.9% β‐blocker 4 × 2‐min with 15% MVIC, ≥3 days/week for 12 weeks, 1‐min rest interval, alternating hands
Ogbutor et al. (2019) [41] RCT Prehypertensive subjects with lifestyle modification, 109M91F, 40.78 ± 6.04 years, 165 ± 9 cm, 75.49 ± 9.8 kg, 31.02 ± 3.72 kg/m2 Hypertension Not on any medications that affect the blood pressure 2 × 2‐min with 30% MVIC, 24 consecutive days, 5‐min rest interval, dominant hand
Okamoto et al. (2020) [42] RCT Asian non‐medicated older adults, 5M6F, 65 ± 11 years, 160.4 ± 10.4 cm, 61.6 ± 9.7 kg, 23.9 ± 2.4 kg/m2 Hypertension Unmedicated 4 × 2‐min with 30% MVIC, 5 days/week for 8 weeks, 1‐min rest interval, unilateral hand
Pagonas et al. (2017) [43] RCT

Regular MVIC group

Hypertensive adults, 9M16F, 58.8 ± 10.6 years, 26.4 ± 3.8 kg/m2, no report of height and weight

Hypertension 24% β‐blocker, 60% ACE i/ARB, 24% DIU, 16% CCB, 0% Other 4 × 2‐min with 30% MVIC, 5 days/week for 12 weeks,1‐min rest interval, alternating hands

Low MVIC group

Hypertensive adults, 11M14F, 62.1 ± 7.1 years, 27.1 ± 7.1 kg/m2, no report of height and weight

Hypertension 36% β‐blocker, 44% ACE i/ARB, 20% DIU, 32% CCB, 4% Other 4 × 2‐min with 5% MVIC, 5 days/week for 12 weeks,1‐min rest interval, alternating hands
Palmeira et al. (2021) [44] RCT Hypertensive patients, 8M23F, 54.3 ± 3.7 years, 74.1 ± 3.2 kg, 29.4 ± 1.1 kg/m2, no report of height Hypertension 7% CCB, 73% DIU, 20% β‐blocker, 20% ACEi, 67% ARB 4 × 2‐min with 30% MVIC for 3 days/week for 12 weeks, 1‐min rest interval, alternating hands
Pinto et al. (2025) [45] RCT Stage 1 hypertension, 12M15F, 71.6 ± 3.6 years, 77.3 ± 8.7 kg, 30.1 ± 3.9 kg/m2, no report of height Hypertension Medication status unclear (not reported) 4 × 45 s with 50% MVIC, 3 days/week for 8 weeks, 1‐min rest interval, bilateral hands
Punia and Kulandaivelan (2020) [46] RCT Stage 1&2 hypertensive patients stratified by age and stage, 10M10F, 30–45 years (range reported only), no report of height, weight, and BMI Hypertension Antihypertensive medication use was recorded as present or absent, with no dosage adjustments during the study; percentage distributions were not provided 4 × 2‐min with 30% MVIC, 3 days/week for 8 weeks, 4‐min rest interval, alternating hands
Ray and Carrasco (2000) [25] RCT Normotensive untrained participants, N = 9, 19–35 years (range reported only), no report of height, weight, and BMI Normotension None 4 × 3‐min with 30% MVIC for 4 days/week for 5weeks, 5‐min rest interval, dominant hand
Silva de Sousa et al. (2024) [47] RCT Treated hypertensive men, 15M0F, 55 ± 7 years, 174 ± 8 cm, 86 ± 15 kg, 28.1 ± 3.5 kg/m2 Hypertension 60% ARB, 7% ACEi, 33% CCB, 40% DIU 4 × 2‐min with 30% MVIC, 3 days/week for 10 weeks, 1‐min rest interval, alternating hands
Stiller‐Moldovan et al. (2012) [48] RCT Medicated hypertensive patients, 7M4F, 60.0 ± 8.5 years, 31.7 ± 7.5 kg/m2, no report of height and weight Hypertension 18.2% DIU, 9.1% ACEi, 9.1% ARB, 18.2% CCB, 9.1% DIU+ACE, 9.1% ACE+β‐blocker, 9.1% ARB+β‐blocker, 9.1% DIU+ACE+β‐blocker, 9.1% DIU+ARB+CCB+β‐blocker (numbers given, percentages derived by authors) 4 × 2‐min with 30% MVIC, 3 days/week for 8 weeks, 1‐min rest interval, alternative hand
Sultana et al. (2024) [49] RCT Middle‐aged prehypertensive men had IHG training with salt restriction less than 2300 mg/day, 30M0F, no report of age, height, weight, and BMI Hypertension Unmedicated

5 × 3‐min with 30% MVIC, 3 days/week for 12 weeks,

5‐min rest interval, each hand alternating days

Taylor et al. (2003) [50] RCT Hypertensive patients, 5M4F, 69.3 ± 6 years; 162 ± 15 cm, 77.5 ± 15.8 kg, no report of BMI Hypertension 44.4% ACEi, 22.2% β‐blockers, 11.1% CCB, 11.1% DIU 4 × 2‐min with 30% MVIC, 3 days/week for 10 weeks, 1‐min rest interval, alternating hands
Verma et al. (2024) [29] RCT Young healthy adults, 40M32F, 19–25 years (range reported only), no report of height, weight, and BMI Normotension None 5 × 3‐min with 30% MVIC, 3 days/week, 5‐min rest interval, dominant hand
Yamagata and Sako (2020) [30] RCT Young women, 0M10F, 21 ± 1 years, 161 ± 8 cm, 56 ± 6 kg, 22 ± 1 kg/m2 Normotension None 4 × 2‐min with 25% MVIC, 3 days/week for 8 weeks, 3‐min rest interval, nondominant hand (adjusted every two weeks if MVIC increased)
Zhang et al. (2024) [55] RCT Overweight college students, 6M6F, no report of age, height, weight, (male: 26.6–28.3 kg/m2; female: 27.1–28.8 kg/m2) Others None 8 × 2‐min with 30% MVIC, 3 days/week for 6 weeks duration, 1‐min rest interval, alternatively hands

Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ANG II B, angiotensin II receptor blocker; ARB, angiotensin receptor blocker; BMI, body mass index, CCB, calcium‐channel blocker; DIU, diuretic; IHG, isometric handgrip; MVIC, maximal voluntary isometric contraction; RCT, randomized controlled trial.

There were 905 IHG participants, with 51% male included in this analysis (two studies not reporting gender distribution [19, 25]). The youngest lower limit reported was 20.2 years, while the highest upper limit was 69.3 years. Across the included studies, participants were primarily middle‐aged adults with body mass index (BMI) values in the overweight. We included all groups that underwent IHG training across the studies, totaling 38 groups. Thirteen groups [13, 20, 25, 26, 27, 28, 29, 30, 31] consisted of participants with normotension and 25 groups [15, 16, 19, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50] included participants with hypertension. The sample size of the normotensive groups was 235, corresponding to an average of 18.1 ± 17.0 participants per group. For the hypertensive groups, 670 participants were allocated, with a mean of 26.8 ± 36.8 per group. Within the hypertensive groups, 14 received antihypertensive pharmacological treatment [15, 16, 32, 34, 35, 36, 37, 39, 40, 43, 44, 46, 47, 48, 50], four were unmedicated [19, 41, 42, 49], and two did not report medication status [38, 45].

3.4. Outcomes of Meta‐Analysis

All studies reported SBP and DBP values, except one study [30], which did not report DBP and that study was therefore excluded from DBP‐specific analyses.

3.4.1. SBP

The pooled analysis showed a significant reduction in SBP following IHG training (MD = –5.38 mmHg, 95% CI –6.91 to –3.85; p < 0.00001; I 2 = 86%; Figure 3). In subgroup analyses, the significant SBP reduction was –4.81 mmHg in normotensive participants (p < 0.00001; I 2 = 86%), and –5.73 mmHg in hypertensive participants (p < 0.00001; I 2 = 85%).

FIGURE 3.

FIGURE 3

Forest plot of systolic blood pressure (SBP).

3.4.2. DBP

The pooled analysis showed a significant reduction in DBP following IHG training (MD = –2.71 mmHg, 95% CI –3.75 to –1.66; p < 0.00001; I 2 = 90%; Figure 4). In subgroup analyses, DBP decreased by –2.45 mmHg in normotensive participants (p < 0.00001; I 2 = 77%) and by –2.95 mmHg in hypertensive participants (p < 0.00001; I 2 = 83%).

FIGURE 4.

FIGURE 4

Forest plot of diastolic blood pressure (DBP).

3.4.3. Sensitivity Analysis

Results of the sensitivity analyses are presented in Figure S1 (SBP) and Figure S2 (DBP). The analysis restricted to low risk of bias studies (excluding studies with some concerns or high risk) is shown in Figure S1 (SBP) and Figure 2 (DBP), whereas the analysis including studies with a low risk of bias or some concerns (excluding high risk studies) is shown in Figure S3 (SBP) and Figure 4 (DBP). Overall, the findings were consistent with the main results.

3.5. Intervention Characteristics

Participants completed 4.1 ± 0.8 sets per session, with 2 ± 0.5 min per set at 27.4 ± 8.7% MVIC; rest intervals averaged 2.3 ± 1.9 min, the program was performed 3.3 ± 1.2 days/week over 9 ± 3.2 weeks. Across groups, alternating hand protocols were 19/38 groups (50%) unilateral protocols were used in 15/39 groups (39.5%), whereas bilateral protocols were used in 4/39 (10.5%).

The frequency distributions of significant and non‐significant SMDs across protocol characteristics are presented in Figure 5. Regarding SBP, protocols with >4 sets per session showed a higher proportion of significant effects (67%). Contractions lasting <2 and >2 min consistently demonstrated significant reductions (100%). Intensities >30% MVIC were associated with significant reductions (100%). Rest intervals >4 min were more effective (100%) than shorter intervals. Unilateral training showed a greater proportion of significant results (40%) than alternating (37%) and bilateral training (25%). Training frequencies of >3 days per week were associated with 44% significance. Interventions equal 8 and >8 weeks demonstrated greater efficacy (38%) compared with longer protocols. For DBP, >4 sets were associated with 67% significant findings. Contractions >2 min showed consistent significance (100%). Intensities >30% MVIC yielded 50% significance, compared to 0% with <30% MVIC (0%) and = 30% MVIC (31%). Rest intervals >4 min (80%) were more effective than shorter intervals. Unilateral training demonstrated 29% significance, compared with 25% for bilateral and 26% with alternating hands. Frequencies >3 days per week yielded 33% significance compared to shorter days. Longer interventions (>8 weeks) resulted in 31% significance, higher than shorter ones.

FIGURE 5.

FIGURE 5

Number of studies reporting the effect of intervention parameters (set, minutes/set, MVIC, rest interval, laterality, days/week, and duration) on SBP and DBP across studies.

3.6. Meta‐Regression

The results of the meta‐regression are presented in Table 3. The total variance explanation was 10.17% for SBP and 39.66% for DBP. For SBP, longer contraction duration (minutes per set) was associated with greater reductions. In contrast, DBP reduction was influenced by both higher training intensity (%MVIC) and longer contraction duration. Interestingly, an increased number of sets per session was associated with a diminished effect, suggesting that fewer sets may be more effective for lowering DBP (Figure 6).

TABLE 3.

Results of meta‐regression in SBP and DBP.

Predictor Systolic blood pressure (SBP) Diastolic blood pressure (DBP)
β (95% CI) p β (95% CI) p
Set (log transformed) 1.515 (0.118, 2.911) 0.034 a 3.278 (1.695, 4.862) <0.001 a
Minutes/set (min) −0.520 (–1.119, 0.078) 0.088 −0.863 (–1.565, –0.171) 0.016 a
MVIC (%) −0.029 (–0.056, –0.008) 0.043 a −0.034 (–0.065, –0.003) 0.032 a
Rest interval (U‐shaped transformed) −0.026 (–0.057, 0.005) 0.099 −0.017 (–0.051, 0.017) 0.322
Days/week (log transformed) 0.727 (0.062, 1.392) 0.032 a 0.016 (–0.722, 0.753) 0.967
Fitting model R 2 = 17.65% R 2 = 39.91%
a

Indicated p < 0.005; Adj, adjusted; MVIC, maximal voluntary isometric contraction.

FIGURE 6.

FIGURE 6

Bubble plots for the dependent variable effect size and independent variable, including (A) SBP‐ set, (B) SBP‐MVIC, (C) SBP‐days/week, (D) DBP‐set, (E) DBP‐MVIC, and (F) DBP‐minutes/set. The weighting is illustrated by the size of the bubbles.

4. Discussion

4.1. Main Findings

The systematic review included 31 studies, with study quality ranging from fair to good on the PEDro scale. A total of 905 IHG participants were analyzed comprising 51% males. Among the included groups, 13 consisted of normotensive participants, and 25 consisted of hypertensive participants. Moderate evidence indicated that IHG significantly reduced both SBP and DBP. In subgroup analyses, significant reductions in SBP were observed in the normotensive (MD: –4.81 mmHg) and hypertensive (MD: –5.73 mmHg) groups. For DBP, significant reductions were found in the normotensive (MD: –2.45 mmHg) and hypertensive (–2.95 mmHg) groups.

With respect to dose parameters for both SBP and DBP, lower training intensity (<30% MVIC) was associated with smaller BP‐lowering effects. Higher weekly frequency (e.g., >3 to 7 days/week) was associated with a diminished effect, suggesting that fewer training days per week may be more effective for reducing SBP. Although based on relatively few studies and therefore interpreted cautiously, a lower number of sets (e.g., <4 sets) showed a trend toward greater reductions in both SBP and DBP. For DBP in particular, greater reductions appeared to be associated with longer contraction duration (>2 to 3 min per set). However, given the relatively low explained variance (SBP R 2 = 17.65%; DBP R 2 = 39.91%), these dose‐response interpretations should be made cautiously.

4.2. Intervention Characteristics

4.2.1. Contraction Duration (Minutes/Set)

The findings indicate that longer contraction durations (minutes per set) might be associated with greater reductions in DBP. Regarding the underlying mechanisms, although the typical IHG training protocol usually consists of four sets of 2‐min contractions [10], prolonged contraction time may enhance local vascular shear stress, thereby increasing the bioavailability of nitric oxide (NO) and improving endothelial function [51, 52]. Such vascular adaptations may represent one of the mechanisms underlying the BP‐lowering effects of IHG. However, no long‐term studies have directly examined the influence of contraction duration on BP outcomes; thus, these interpretations were based primarily on short‐term effects.

One study [53] reported that BP reactivity was dependent on handgrip contraction duration, with sustained contractions lasting four 2‐min contractions eliciting greater peak responses than those lasting only sixteen 30‐s contractions. Moreover, the four 2‐min protocol maintained elevated BP throughout the entire 30‐min recovery period, whereas the short‐duration protocol allowed BP to return to baseline within 15 min. These findings suggest that longer sustained contractions may prolong cardiovascular stress or delay recovery mechanisms. Taken together, these results suggest that prolonged contractions may elevate local vascular shear stress, thereby augmenting NO availability and ultimately contributing to BP reduction. Nevertheless, the contraction duration inference was based on a relatively small number of studies in the current regression analyses, and future well‐designed trials are needed to directly test the effect of contraction duration on long‐term BP outcomes.

4.2.2. Intensity (MVIC)

Lower training intensity (<30% MVIC) may yield smaller BP‐lowering effects in both SBP and DBP. This finding is consistent with three previous studies. Two studies [16, 43] demonstrated that IHG training at 30% MVIC significantly reduced both SBP and DBP, whereas training at 5% MVIC showed no clear effect. Another study [13] comparing 5% and 10% MVIC found no reduction in DBP in either group. These results suggest that DBP may exhibit a dose‐response relationship to training intensity. Importantly, very low‐intensity MVIC protocols may function more like a sham condition and therefore may be insufficient to elicit meaningful BP reductions. However, no long‐term IHG interventions have investigated different intensities above the commonly studied 30% MVIC. Future RCTs are needed to further clarify the effects of different intensity levels on BP.

4.2.3. Sets

A finding is the inverse effect of training sets, whereby increasing the number of sets per session was associated with attenuated SBP and DBP reductions, suggesting that fewer sets may be more effective. This indicates that vascular pressure regulation progressively accumulates with additional sets. One study [54] indicated that the total power spectral density of heart rate variability (PSD‐RRI) showed a stepwise decline across sets, reflecting sustained withdrawal of vagal activity. It suggested that exceeding a certain threshold of training volume may lead to excessive sympathetic activation or muscle fatigue, thereby limiting long‐term reductions in TPR and hindering improvements in BP. Although the traditional IHG protocol typically employs four sets, the present findings suggest that alternative set prescriptions may warrant consideration. However, only five included studies used protocols other than four sets, and thus this inference should be interpreted cautiously and requires confirmation in future trials. Future research using direct measures of autonomic activity is warranted to validate this mechanism.

4.2.4. Frequency (Days/Week)

Although our analyses suggest that higher weekly frequency may be associated with smaller SBP reductions, direct evidence supporting a detrimental effect of higher‐frequency IHG training remains limited. Instead, the existing IHG literature more consistently indicates no additional benefit with increased frequency, consistent with a plateau pattern. For example, Chen et al. [20] compared two sessions/week versus four sessions/week over 4 weeks and observed SBP reductions in both groups with no between‐group difference. Similarly, Cohen et al. [19] reported that after achieving a significant SBP reduction with three sessions/week for 12 weeks, reducing the frequency to one session/week for an additional 12 weeks largely maintained the SBP improvement, suggesting that lower training frequency may be sufficient, at least for maintaining BP‐lowering effects. Future study should compare different frequencies in the population to fully understand the dosage effects on BP.

4.3. Limitations

This study has several limitations. First, as a systematic review, it was not possible to obtain detailed information regarding patients’ compliance with the IHG protocol. Second, the included studies demonstrated relatively high heterogeneity, which reduced the overall level of evidence. Third, the low explanatory power of the SBP model suggests that factors other than dosage (e.g., genetics, diet, and adherence) play a major role. In addition, the high heterogeneity is a major caveat, indicating considerable between‐study variability. Factors beyond exercise dosage (e.g., medication use, adherence, baseline BP, and lifestyle factors) likely contribute substantially to between‐study differences. As a result, the SBP dose‐response estimates should be interpreted cautiously. Finally, although the use of medications is documented in Table 2, the potential effects of these medications may not be fully accounted for in the analysis.

5. Conclusions

This systematic review and meta‐analysis, encompassing 31 studies with 905 participants, provides moderate evidence that IHG effectively reduces both SBP and DBP. Significant BP reductions were observed across normotensive and hypertensive groups. The DBP reductions were pronounced in normotensive and hypertensive participants. In addition, slight benefits were observed in hypertensive individuals compared with normotensive participants.

Traditionally, the most common IHG protocol has involved four 2‐min unilateral contractions at 30% MVIC with 1‐min rest interval, three times per week for at least 8 weeks. However, the present pooled meta‐analysis has identified specific intervention characteristics to explore whether specific intervention characteristics might further optimize outcomes. The finding suggests that within the dosage ranges represented in the included studies, variations in training prescription do not appear to meaningfully modify SBP reduction. In contrast, lower training intensity (<30% MVIC) may have less effects on both SBP and DBP reduction. Higher weekly frequency (e.g., >3 to 7 days/week) was associated with a diminished effect, suggesting that fewer training days per week may be more effective for reducing SBP. Overall, the evidence supports a pragmatic, literature‐consistent prescription for an individual with hypertension or normotension (at risk for hypertension) would be four sets of 2‐min unilateral contractions at ≥30% MVIC, performed ≤3 times per week for a minimum of 8 weeks. Note that these recommendations should not be interpreted as prescriptive clinical guidelines but rather as summary patterns observed across heterogeneous studies. Nevertheless, it should also be acknowledged that BP responses may be driven largely by factors beyond dosage (e.g., genetics, diet, medication use, and adherence), rather than by the relatively modest dosage differences evaluated in this meta‐analysis.

Author Contributions

Chia‐Wei Lin: conceptualization, data collection, investigation, methodology, writing – draft, writing – revision. Ian B. Jun: data collection, investigation, writing – review. Vincent Igbo: data collection, investigation, writing – review. Amir Babaniamansour: data collection, investigation, writing – review. Lingyue Meng: data collection, investigation, writing – review. Cheng‐Feng Lin: supervision, investigation, writing – review. Yih‐Kuen Jan: conceptualization, supervision, project administration, investigation, methodology, writing – draft, writing – revision.

Conflicts of Interest

The authors declare no conflicts of interest.

Supporting information

Supplementary File1: jch70246‐sup‐0001‐SuppMat.docx

JCH-28-e70246-s001.docx (125.6KB, docx)

Data Availability Statement

Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

References

  • 1. Lawes C. M., Bennett D. A., Feigin V. L., and Rodgers A., “Blood Pressure and Stroke: An Overview of Published Reviews,” Stroke; A Journal of Cerebral Circulation 35, no. 4 (2004): 1024. [PubMed] [Google Scholar]
  • 2. Afzal M. R., Savona S., Mohamed O., Mohamed‐Osman A., and Kalbfleisch S. J., “Hypertension and Arrhythmias,” Heart Failure Clinics 15, no. 4 (2019): 543–550. [DOI] [PubMed] [Google Scholar]
  • 3. World Health Organization , Global Report on Hypertension 2025: High Stakes ‐ Turning Evidence into Action, 2025.
  • 4. Rodrigues G. D., Lima L. S., da Silva N. C. S., et al., “Are Home‐Based Exercises Effective to Reduce Blood Pressure in Hypertensive Adults? A Systematic Review,” Clinical Hypertension 28, no. 1 (2022): 28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Hansford H. J., Parmenter B. J., McLeod K. A., et al., “The Effectiveness and Safety of Isometric Resistance Training for Adults With High Blood Pressure: A Systematic Review and Meta‐Analysis,” Hypertension Research—Clinical & Experimental 44, no. 11 (2021): 1373–1384. [DOI] [PubMed] [Google Scholar]
  • 6. Wehrmann A., Tian E. J., Tyack E. L., and Kumar S., “The Evidence of Effectiveness of Isometric Resistance Training on the Management of Hypertension in Adults: An Umbrella Review,” Blood Pressure Monitoring 28, no. 4 (2023): 171–184. [DOI] [PubMed] [Google Scholar]
  • 7. Edwards J. J., Coleman D. A., Ritti‐Dias R. M., et al., “Isometric Exercise Training and Arterial Hypertension: An Updated Review,” Sports Medicine 54, no. 6 (2024): 1459–1497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Rickson J. J., Maris S. A., and Headley S. A. E., “Isometric Exercise Training: A Review of Hypothesized Mechanisms and Protocol Application in Persons With Hypertension,” International Journal of Exercise Science 14, no. 2 (2021): 1261–1276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. McEvoy J. W., McCarthy C. P., Bruno R. M., et al., “2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension: Developed by the Task Force on the Management of Elevated Blood Pressure and Hypertension of the European Society of Cardiology (ESC) and Endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO),” European Heart Journal 45, no. 38 (2024): 3912–4018.39210715 [Google Scholar]
  • 10. Whelton P. K., Carey R. M., Aronow W. S., et al., “ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines,” Hypertension 71, no. 6 (2018): e13–e115. [DOI] [PubMed] [Google Scholar]
  • 11. Loaiza‐Betancur A. F. and Chulvi‐Medrano I., “Is Low‐Intensity Isometric Handgrip Exercise an Efficient Alternative in Lifestyle Blood Pressure Management? A Systematic Review,” Sports Health 12, no. 5 (2020): 470–477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Lin S., Sun P., Huang L., Hernandez M., Yu H., and Jan Y. K., “Effects of the Intensity, Duration and Muscle Mass Factors of Isometric Exercise on Acute Local Muscle Hemodynamic Responses and Systematic Blood Pressure Regulation,” Frontiers in Bioengineering and Biotechnology 12 (2024): 1444598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Hess N. C., Carlson D. J., Inder J. D., Jesulola E., McFarlane J. R., and Smart N. A., “Clinically Meaningful Blood Pressure Reductions With Low Intensity Isometric Handgrip Exercise. A Randomized Trial,” Physiological Research 65, no. 3 (2016): 461–468. [DOI] [PubMed] [Google Scholar]
  • 14. Javidi M., Ahmadizad S., Argani H., et al., “Effect of Lower‐ Versus Higher‐Intensity Isometric Handgrip Training in Adults With Hypertension: A Randomized Controlled Trial,” Journal of Cardiovascular Development and Disease 9, no. 9 (2022): 287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Nemoto Y., Yamaki Y., Takahashi T., Satoh T., Konno S., and Munakata M., “Effects of Low‐Intensity Isometric Handgrip Training on Home Blood Pressure in Hypertensive Patients: A Randomized Controlled Trial,” Hypertension Research 48, no. 2 (2025): 710–719. [DOI] [PubMed] [Google Scholar]
  • 16. Carlson D. J., Inder J., Palanisamy S. K. A., McFarlane J. R., Dieberg G., and Smart N. A., “The Efficacy of Isometric Resistance Training Utilizing Handgrip Exercise for Blood Pressure Management: A Randomized Trial,” Medicine 95, no. 52 (2016): e5791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Zhu H., He L., Guo J., Huang B., Elliott J., and Jan Y. K., “Effects of Neuromuscular Fatigue Induced by Various Modes of Isometric Handgrip Exercise on Post‐Exercise Blood Pressure Responses,” Journal of Sports Medicine and Physical Fitness 65, no. 4 (2025): 571–582. [DOI] [PubMed] [Google Scholar]
  • 18. Millar P. J., Bray S. R., McGowan C. L., MacDonald M. J., and McCartney N., “Effects of Isometric Handgrip Training Among People Medicated for Hypertension: A Multilevel Analysis,” Blood Pressure Monitoring 12, no. 5 (2007): 307–314. [DOI] [PubMed] [Google Scholar]
  • 19. Cohen D. D., Aroca‐Martinez G., Carreño‐Robayo J., et al., “Reductions in Systolic Blood Pressure Achieved by Hypertensives With Three Isometric Training Sessions per Week Are Maintained With a Single Session per Week,” Journal of Clinical Hypertension (Greenwich, Conn) 25, no. 4 (2023): 380–387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Chen Y. C., Cheng C. Y., McNally B., et al., “Low and High Frequency Isometric Handgrip Exercise Training Similarly Reduce Resting Blood Pressure in Young Normotensive Adults: A Randomised Controlled Trial,” Journal of Sports Sciences 43, no. 3 (2025): 234–244. [DOI] [PubMed] [Google Scholar]
  • 21. Higgins J., Thomas J., Chandler J., et al., Cochrane Handbook for Systematic Reviews of Interventions (The Cochrane Collaboration, 2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Adler Y., Fisman E. Z., Koren‐Morag N., et al., “Left Ventricular Diastolic Function in Trained Male Weightlifters at Rest and During Isometric Exercise,” American Journal of Cardiology 102, no. 1 (2008): 97–101. [DOI] [PubMed] [Google Scholar]
  • 23. Maher C. G., Sherrington C., Herbert R. D., Moseley A. M., and Elkins M., “Reliability of the PEDro Scale for Rating Quality of Randomized Controlled Trials,” Physical Therapy 83, no. 8 (2003): 713–721. [PubMed] [Google Scholar]
  • 24. Lin C.‐C., Kao S.‐C., Chueh T.‐Y., and Hung T.‐M., “The Effects of Chronic Exercise Interventions on Executive Function in Healthy Older Adults and Optimal Training Characteristics: A Systematic Review Based on Randomized Controlled Trials,” Psychology of Sport and Exercise 80 (2025): 102925. [DOI] [PubMed] [Google Scholar]
  • 25. Ray C. A. and Carrasco D. I., “Isometric Handgrip Training Reduces Arterial Pressure at Rest Without Changes in Sympathetic Nerve Activity,” American Journal of Physiology—Heart and Circulatory Physiology 279, no. 1 (2000): H245–H249. [DOI] [PubMed] [Google Scholar]
  • 26. Baross A. W., Hodgson D. A., Padfield S. L., and Swaine I. L., “Reductions in Resting Blood Pressure in Young Adults When Isometric Exercise Is Performed Whilst Walking,” Journal of Sports Medicine Hindawi Print 2017 (2017): 7123834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Goessler K. F., Buys R., VanderTrappen D., Vanhumbeeck L., and Cornelissen V. A., “A Randomized Controlled Trial Comparing Home‐Based Isometric Handgrip Exercise Versus Endurance Training for Blood Pressure Management,” Journal of the American Society of Hypertension 12, no. 4 (2018): 285–293. [DOI] [PubMed] [Google Scholar]
  • 28. Millar P. J., Bray S. R., MacDonald M. J., and McCartney N., “The Hypotensive Effects of Isometric Handgrip Training Using an Inexpensive Spring Handgrip Training Device,” Journal of Cardiopulmonary Rehabilitation & Prevention 28, no. 3 (2008): 203–207. [DOI] [PubMed] [Google Scholar]
  • 29. Verma N. K., Shete S., and Verma A., “Isometric Handgrip Exercise Training as a Potential Tool for Identifying and Regulating Blood Pressure in Young Healthy Adults,” National Journal of Physiology, Pharmacy and Pharmacology 14, no. 8 (2024): 1656–1661. [Google Scholar]
  • 30. Yamagata T. and Sako T., “High Cardiovascular Reactivity and Muscle Strength Attenuate Hypotensive Effects of Isometric Handgrip Training in Young Women: A Randomized Controlled Trial,” Clinical and Experimental Hypertension 42, no. 7 (2020): 595–600. [DOI] [PubMed] [Google Scholar]
  • 31. Anjum A., Vanajakshi B. J., and Fatima Y., “A Study on the Effect of Isometric Exercise Training on Blood Pressure in Normotensive Subjects,” International Journal of Academic Medicine and Pharmacy 6, no. 1 (2024): 1116–1118. [Google Scholar]
  • 32. Badrov M. B., Horton S., Millar P. J., and McGowan C. L., “Cardiovascular Stress Reactivity Tasks Successfully Predict the Hypotensive Response of Isometric Handgrip Training in Hypertensives,” Psychophysiology 50, no. 4 (2013): 407–414. [DOI] [PubMed] [Google Scholar]
  • 33. Badrov M. B., Bartol C. L., DiBartolomeo M. A., Millar P. J., McNevin N. H., and McGowan C. L., “Effects of Isometric Handgrip Training Dose on Resting Blood Pressure and Resistance Vessel Endothelial Function in Normotensive Women,” European Journal of Applied Physiology 113, no. 8 (2013): 2091–2100. [DOI] [PubMed] [Google Scholar]
  • 34. Cahu Rodrigues S. L., Farah B. Q., Silva G., et al., “Vascular Effects of Isometric Handgrip Training in Hypertensives,” Clinical & Experimental Hypertension (New York) 42, no. 1 (2020): 24–30. [DOI] [PubMed] [Google Scholar]
  • 35. Danielsen M. B., Andersen S., Ryg J., Bruun N. H., Madeleine P., and Jorgensen M. G., “Effect of a Home‐Based Isometric Handgrip Training Programme on Systolic Blood Pressure in Adults: A Randomised Assessor‐Blinded Trial,” Journal of Sports Sciences 41, no. 20 (2023): 1815–1823. [DOI] [PubMed] [Google Scholar]
  • 36. Farah B. Q., Rodrigues S. L. C., Silva G. O., et al., “Supervised, but Not Home‐Based, Isometric Training Improves Brachial and Central Blood Pressure in Medicated Hypertensive Patients: A Randomized Controlled Trial,” Frontiers in Physiology 9 (2018): 961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Fecchio R. Y., de Sousa J. C. S., Oliveira‐Silva L., et al., “Effects of Dynamic, Isometric and Combined Resistance Training on Blood Pressure and Its Mechanisms in Hypertensive Men,” Hypertension Research 46, no. 4 (2023): 1031–1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Herrod P. J. J., Lund J. N., and Phillips B. E., “Time‐Efficient Physical Activity Interventions to Reduce Blood Pressure in Older Adults: A Randomised Controlled Trial,” Age and Ageing 50, no. 3 (2021): 980–984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. SY J., Yoon E. S., Kim H. J., et al., “Isometric Handgrip Versus Aerobic Exercise: A Randomized Trial Evaluating Central and Ambulatory Blood Pressure Outcomes in Older Hypertensive Participants,” Journal of Hypertension 43, no. 2 (2025): 351–358. [DOI] [PubMed] [Google Scholar]
  • 40. Nemoto Y., Satoh T., Takahashi T., et al., “Effects of Isometric Handgrip Training on Home Blood Pressure Measurements in Hypertensive Patients: A Randomized Crossover Study,” Internal Medicine 60, no. 14 (2021): 2181–2188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Ogbutor G. U., Nwangwa E. K., and Uyagu D. D., “Isometric Handgrip Exercise Training Attenuates Blood Pressure in Prehypertensive Subjects at 30% Maximum Voluntary Contraction,” Nigerian Journal of Clinical Practice 22, no. 12 (2019): 1765–1771. [DOI] [PubMed] [Google Scholar]
  • 42. Okamoto T., Hashimoto Y., and Kobayashi R., “Isometric Handgrip Training Reduces Blood Pressure and Wave Reflections in East Asian, Non‐Medicated, Middle‐Aged and Older Adults: A Randomized Control Trial,” Aging‐Clinical & Experimental Research 32, no. 8 (2020): 1485–1491. [DOI] [PubMed] [Google Scholar]
  • 43. Pagonas N., Vlatsas S., Bauer F., et al., “Aerobic Versus Isometric Handgrip Exercise in Hypertension: A Randomized Controlled Trial,” Journal of Hypertension 35, no. 11 (2017): 2199–2206. [DOI] [PubMed] [Google Scholar]
  • 44. Palmeira A. C., Farah B. Q., Silva G. O. D., et al., “Effects of Isometric Handgrip Training on Blood Pressure Among Hypertensive Patients Seen Within Public Primary Healthcare: A Randomized Controlled Trial,” Sao Paulo Medical Journal = Revista Paulista de Medicina 139, no. 6 (2021): 648–656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Pinto D., Dias N., Garcia C., et al., “Effect of Home‐Based Isometric Training on Blood Pressure in Older Adults With High Normal BP or Stage I Hypertension: A Randomized Controlled Trial,” Journal of the American Geriatrics Society 73, no. 2 (2025): 574–582. [DOI] [PubMed] [Google Scholar]
  • 46. Punia S. and Kulandaivelan S., “Home‐Based Isometric Handgrip Training on RBP in Hypertensive Adults‐Partial Preliminary Findings from RCT,” Physiotherapy Research International 25, no. 1 (2020): e1806. [DOI] [PubMed] [Google Scholar]
  • 47. Silva de Sousa J. C., Fecchio R. Y., Oliveira‐Silva L., et al., “Effects of Dynamic, Isometric, and Combined Resistance Training on Ambulatory Blood Pressure in Treated Men With Hypertension: A Randomized Controlled Trial,” Journal of Human Hypertension 38, no. 12 (2024): 796–805. [DOI] [PubMed] [Google Scholar]
  • 48. Stiller‐Moldovan C., Kenno K., and McGowan C. L., “Effects of Isometric Handgrip Training on Blood Pressure (Resting and 24 h Ambulatory) and Heart Rate Variability in Medicated Hypertensive Patients,” Blood Pressure Monitoring 17, no. 2 (2012): 55–61. [DOI] [PubMed] [Google Scholar]
  • 49. Sultana N., Rama Devi M., and Ambareesha K., “Blood Pressure Response to 12 Weeks of Isometric Handgrip Exercise Training in Prehypertensive Adult Males,” National Journal of Physiology, Pharmacy and Pharmacology 14, no. 10 (2024): 2044–2047. [Google Scholar]
  • 50. Taylor A. C., McCartney N., Kamath M. V., and Wiley R. L., “Isometric Training Lowers Resting Blood Pressure and Modulates Autonomic Control,” Medicine & Science in Sports & Exercise 35, no. 2 (2003): 251–256. [DOI] [PubMed] [Google Scholar]
  • 51. Swift H. T., O'Driscoll J. M., Coleman D. D., Caux A., and Wiles J. D., “Acute Cardiac Autonomic and Haemodynamic Responses to Leg and Arm Isometric Exercise,” European Journal of Applied Physiology 122, no. 4 (2022): 975–985. [DOI] [PubMed] [Google Scholar]
  • 52. Olher R. R., Rosa T. S., Souza L. H. R., et al., “Isometric Exercise With Large Muscle Mass Improves Redox Balance and Blood Pressure in Hypertensive Adults,” Medicine & Science in Sports & Exercise 52, no. 5 (2020): 1187–1195. [DOI] [PubMed] [Google Scholar]
  • 53. Bentley D. C. and Thomas S. G., “Characterizing and Comparing Acute Responses of Blood Pressure, Heart Rate, and Forearm Blood Flow to 2 Handgrip Protocols,” Journal of Cardiopulmonary Rehabilitation and Prevention 38, no. 6 (2018): 400–405. [DOI] [PubMed] [Google Scholar]
  • 54. Taylor K. A., Wiles J. D., Coleman D. D., Sharma R., and O'Driscoll J. M., “Continuous Cardiac Autonomic and Hemodynamic Responses to Isometric Exercise,” Medicine & Science in Sports & Exercise 49, no. 8 (2017): 1511–1519. [DOI] [PubMed] [Google Scholar]
  • 55. Zhang T., Yang Y., Wang K., Liu S., and Luo J., “Study on the Effect of Full Body Isometric Resistance Training on Cardiovascular Pressure Response,” Journal of Hypertension 43, no. 2 (2025): 211–220. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary File1: jch70246‐sup‐0001‐SuppMat.docx

JCH-28-e70246-s001.docx (125.6KB, docx)

Data Availability Statement

Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.


Articles from The Journal of Clinical Hypertension are provided here courtesy of Wiley

RESOURCES